Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingfei Xiaoyan Wan
- Development stage
- Unknown
- Lead developer
- Tianjin Zhongxin Pharmaceutical Group Corporation Ltd. Darentang Pharmaceutical Factory
- Administration
- Oral
01
Overview
Qingfei Xiaoyan Wan is a Traditional Chinese Medicine (TCM) formulation developed by Tianjin Zhongxin Pharmaceutical Group (Darentang Pharmaceutical Factory). It is primarily indicated for the treatment of respiratory conditions such as acute bronchitis and acute upper respiratory tract infections, specifically targeting the 'phlegm-heat obstructing the lungs' syndrome. The formulation is a multi-ingredient product that traditionally utilized antelope horn; however, recent clinical development has focused on a version utilizing goat horn (Caprae Hircus Cornu) as a sustainable substitute. The medicine is designed to clear heat, detoxify the lungs, resolve phlegm, and relieve cough and asthma. It is currently undergoing Phase III clinical evaluation in China to confirm its efficacy and safety in treating acute inflammatory conditions of the respiratory tract.
- Brand names
- Qingfei Xiaoyan Wan
- Other names
- Qingfei Xiaoyan PillsQingfei Xiaoyan Wan (Goat Horn)
02
Targets
MAPK3 (Mitogen-activated protein kinase 1)
Beyond the preview
Go deeper on Qingfei Xiaoyan Wan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qingfei Xiaoyan Wan.